Urinary cortisol and six-year risk of all-cause and cardiovascular mortality

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 11, 2010, Pages 4959-4964

  Vogelzangs, Nicole ^a   Beekman, Aartjan T F ^a   Milaneschi, Yuri ^b,c   Bandinelli, Stefania ^d   Ferrucci, Luigi ^b   Penninx, Brenda W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c Tuscany Regional Health Agency   (Italy)

^d SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; DEATH CERTIFICATE; DISEASE ASSOCIATION; FEMALE; HEART DEATH; HIGH RISK PATIENT; HUMAN; HYDROCORTISONE URINE LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

EID: 78049521189     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0192     Document Type: Article

References (36)

1. Björntorp P 2001 Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2:73-86
2. Chrousos GP, Gold PW 1992 The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267:1244-1252
3. Whitworth JA, Williamson PM, Mangos G, Kelly JJ 2005 Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag 1:291-299
4. Franchimont D, Kino T, Galon J, Meduri GU, Chrousos G 2002 Glucocorticoids and inflammation revisited: the state of the art. NIH clinical staff conference. Neuroimmunomodulation 10:247-260
5. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, Shipley MJ, Kumari M, Andrew R, Seckl JR, Papadopoulos A, Checkley S, Rumley A, Lowe GD, Stansfeld SA, Marmot MG 2002 Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 106:2659-2665
6. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E, Connell JM 1999 Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 33:1364-1368 (Pubitemid 29282655)
7. Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW 2007 Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32:151-159
8. Dekker MJ, Koper JW, van Aken MO, Pols HA, Hofman A, de Jong FH, Kirschbaum C, Witteman JC, Lamberts SW, Tiemeier H 2008 Salivary cortisol is related to atherosclerosis of carotid arteries. J Clin Endocrinol Metab 93:3741-3747
9. Matthews K, Schwartz J, Cohen S, Seeman T 2006 Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med 68:657-661
10. Björntorp P 2001 Heart and soul: stress and the metabolic syndrome. Scand Cardiovasc J 35:172-177
11. Rosmond R 2005 Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 30:1-10
12. Güder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Störk S 2007 Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 115:1754-1761
13. Marklund N, Peltonen M, Nilsson TK, Olsson T 2004 Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med 256:15-21 (Pubitemid 38813615)
14. Tenerz A, Nilsson G, Forberg R, Ohrvik J, Malmberg K, Berne C, Leppert J 2003 Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients. J Intern Med 254:494-503
15. Rotman-Pikielny P, Roash V, Chen O, Limor R, Stern N, Gur HG 2006 Serum cortisol levels in patients admitted to the department of medicine: prognostic correlations and effects of age, infection, and comorbidity. Am J Med Sci 332:61-67
16. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P 2005 Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 112:332-340
17. Boscarino JA 2008 Psychobiologic predictors of disease mortality after psychological trauma: implications for research and clinical surveillance. J Nerv Ment Dis 196:100-107
18. Schoorlemmer RM, Peeters GM, van Schoor NM, Lips P 2009 Relationships between cortisol level, mortality and chronic diseases in older persons. Clin Endocrinol (Oxf) 71:779-786
19. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB, Guralnik JM 2000 Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 48:1618-1625
20. National Kidney Foundation 2002 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1-S266
21. Radloff LS 1977 The CES-D Scale:Aself-report depression scale for research in the general population. Appl Psychol Measure 1:385-401
22. Folstein MF, Folstein SE, McHugh PR 1975 Mini-mental state: a practical method for grading the state of patients for the clinician. J Psychiatr Res 12:189-198
23. Guralnik JM, Fried LP, Simonsick EM, Kasper JD, Lafferty ME 1995 The Women's Health and Aging Study. Health and social characteristics of older women with disability. Bethesda, MD: National Institute on Aging; NIH Publication no. 95-4009
24. Pasquali R, Vicennati V 2000 Activity of the hypothalamic-pituitary- adrenal axis in different obesity phenotypes. Int J Obes Relat Metab Disord 24(Suppl 2):S47-S49
25. Lightman SL 2008 The neuroendocrinology of stress: a never ending story. J Neuroendocrinol 20:880-884
26. Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW 2009 Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 66:617-626
27. Van Cauter E, Leproult R, Kupfer DJ 1996 Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81:2468-2473
28. Veldhuis JD, Keenan DM, Roelfsema F, Iranmanesh A 2005 Aging-related adaptations in the corticotropic axis: modulation by gender. Endocrinol Metab Clin North Am 34:993-1014
29. Otte C, Hart S, Neylan TC, Marmar CR, Yaffe K, Mohr DC 2005 A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 30:80-91 (Pubitemid 39195047)
30. Willerson JT, Ridker PM 2004 Inflammation as a cardiovascular risk factor. Circulation 109:II2-II10
31. Brönnegård M, Arner P, Hellström L, Akner G, Gustafsson JA 1990 Glucocorticoid receptor messenger ribonucleic acid in different regions of human adipose tissue. Endocrinology 127:1689-1696
32. Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T 2008 Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 52:605-615
33. Nicklas BJ, Penninx BW, Cesari M, Kritchevsky SB, Newman AB, Kanaya AM, Pahor M, Jingzhong D, Harris TB 2004 Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study. Am J Epidemiol 160:741-749
34. Bauer ME, Jeckel CM, Luz C 2009 The role of stress factors during aging of the immune system. Ann NY Acad Sci 1153:139-152
35. Rickard AJ, Young MJ 2009 Corticosteroid receptors, macrophages and cardiovascular disease. J Mol Endocrinol 42:449-459
36. Jaffe IZ, Tintut Y, Newfell BG, Demer LL, Mendelsohn ME 2007 Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol 27:799-805 (Pubitemid 46606709)